However, NASH Slc39a5-/- mice were not protected from hepatic steatosis or hepatocyte hypertrophy (Figure 6C and D, Figure 6—figure supplement 1C and D). The gene discussed is SLC39A5; the disease is metabolic dysfunction-associated steatohepatitis.